Search Results - "GARNERO, P."

Refine Results
  1. 1

    The multiple facets of periostin in bone metabolism by Merle, B., Garnero, P.

    Published in Osteoporosis international (01-04-2012)
    “…Periostin is a matricellular glutamate-containing protein expressed during ontogenesis and in adult connective tissues submitted to mechanical strains…”
    Get full text
    Journal Article
  2. 2

    Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards by Vasikaran, S, Eastell, R, Bruyère, O, Foldes, A. J, Garnero, P, Griesmacher, A, McClung, M, Morris, H. A, Silverman, S, Trenti, T, Wahl, D. A, Cooper, C, Kanis, J. A

    Published in Osteoporosis international (01-02-2011)
    “…Summary The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommend that a…”
    Get full text
    Journal Article Web Resource
  3. 3

    Biological markers in osteoarthritis by Rousseau, J.Ch, Garnero, P

    Published in Bone (New York, N.Y.) (01-08-2012)
    “…Abstract Osteoarthritis (OA) is considered as a chronic disease with a long “silent” period. The diagnosis is generally based on clinical symptoms and…”
    Get full text
    Journal Article
  4. 4

    The role of collagen in bone strength by VIGUET-CARRIN, S, GARNERO, P, DELMAS, P. D

    Published in Osteoporosis international (01-03-2006)
    “…Bone is a complex tissue of which the principal function is to resist mechanical forces and fractures. Bone strength depends not only on the quantity of bone…”
    Get full text
    Journal Article
  5. 5

    The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort by Garnero, P., Sornay-Rendu, E., Chapurlat, R.

    Published in Osteoarthritis and cartilage (01-04-2020)
    “…Identifying objective risk-indicators for total joint replacement (TJR) is useful to enrich population at high risk in OA clinical trials. We investigate the…”
    Get full text
    Journal Article
  6. 6

    Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study by Garnero, P., Sornay-Rendu, E., Munoz, F., Borel, O., Chapurlat, R. D.

    Published in Osteoporosis international (01-02-2013)
    “…Summary Sclerostin is a key regulator of bone formation. In a population of 572 postmenopausal women (mean age, 67 years) followed prospectively for a median…”
    Get full text
    Journal Article
  7. 7

    Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis by Kraus, V.B, Burnett, B, Coindreau, J, Cottrell, S, Eyre, D, Gendreau, M, Gardiner, J, Garnero, P, Hardin, J, Henrotin, Y, Heinegård, D, Ko, A, Lohmander, L.S, Matthews, G, Menetski, J, Moskowitz, R, Persiani, S, Poole, A.R, Rousseau, J.-C, Todman, M

    Published in Osteoarthritis and cartilage (01-05-2011)
    “…Summary Objective Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of…”
    Get full text
    Journal Article Conference Proceeding Web Resource
  8. 8

    Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY Study by Rousseau, J. C, Sornay-Rendu, E, Bertholon, C, Chapurlat, R, Garnero, P

    “…Purpose: Periostin (POSTN) is a secreted γ-carboxyglutamic acid-containing protein expressed mainly in the periosteum in adult individuals. POSNT deficient…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Body mass index as a predictor of fracture risk : A meta-analysis by DE LAET, C, KANIS, J. A, MCCLOSKEY, E. V, MELLSTROM, D, MELTON, L. J, MEUNIER, P. J, POIS, H. A. P, REEVE, J, SILMAN, A, TENENHOUSE, A, ODEN, A, JOHANSON, H, JOHNELL, O, DELMAS, P, EISMAN, J. A, KROGER, H, FUJIWARA, S, GARNERO, P

    Published in Osteoporosis international (01-11-2005)
    “…Low body mass index (BMI) is a well-documented risk factor for future fracture. The aim of this study was to quantify this effect and to explore the…”
    Get full text
    Journal Article
  12. 12

    A meta-analysis of previous fracture and subsequent fracture risk by Kanis, J.A, Johnell, O, De Laet, C, Johansson, H, Oden, A, Delmas, P, Eisman, J, Fujiwara, S, Garnero, P, Kroger, H, McCloskey, E.V, Mellstrom, D, Melton, L.J, Pols, H, Reeve, J, Silman, A, Tenenhouse, A

    Published in Bone (New York, N.Y.) (01-08-2004)
    “…Previous fracture is a well-documented risk factor for future fracture. The aim of this study was to quantify this risk on an international basis and to…”
    Get full text
    Journal Article
  13. 13

    Establishing a reference range for bone turnover markers in young, healthy women by Glover, S.J, Garnero, P, Naylor, K, Rogers, A, Eastell, R

    Published in Bone (New York, N.Y.) (01-04-2008)
    “…Abstract Introduction Biochemical markers of bone turnover (BTMs) are important in determining fracture risk in postmenopausal women; high levels being…”
    Get full text
    Journal Article
  14. 14

    Increased Dickkopf-1 expression in breast cancer bone metastases by Voorzanger-Rousselot, N, Goehrig, D, Journe, F, Doriath, V, Body, J J, Clézardin, P, Garnero, P

    Published in British journal of cancer (08-10-2007)
    “…The aim of this study was to determine whether Dickkopf-1 (Dkk-1) expression in breast cancer was associated with bone metastases. We first analysed Dkk-1…”
    Get full text
    Journal Article
  15. 15

    Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study by Rousseau, J.C, Sornay-Rendu, E, Bertholon, C, Garnero, P, Chapurlat, R

    Published in Osteoarthritis and cartilage (01-10-2015)
    “…Summary Objective Our aim was to investigate the relationships between serum periostin (POSTN) and both prevalence and incidence/progression of knee…”
    Get full text
    Journal Article
  16. 16

    Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate by Eastell, R, Barton, I, Hannon, Ra, Chines, A, Garnero, P, Delmas, Pd

    Published in Journal of bone and mineral research (01-06-2003)
    “…Changes in the level of biochemical markers of bone resorption with risedronate treatment for osteoporosis were examined as a surrogate for the decrease in…”
    Get full text
    Journal Article
  17. 17

    Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The Decalyos II study by CHAPUY, M. C, PAMPHILE, R, PARIS, E, KEMPF, C, SCHLICHTING, M, ARNAUD, S, GARNERO, P, MEUNIER, P. J

    Published in Osteoporosis international (01-03-2002)
    “…Vitamin D insufficiency and low calcium intake contribute to increase parathyroid function and bone fragility in elderly people. Calcium and vitamin D…”
    Get full text
    Journal Article
  18. 18

    Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study by Garnero, P, Munoz, F, Sornay-Rendu, E, Delmas, P.D

    Published in Bone (New York, N.Y.) (01-03-2007)
    “…Abstract Introduction Vitamin D status is considered as an important determinant of bone health but supplementation trials with vitamin D3 have yielded…”
    Get full text
    Journal Article
  19. 19

    The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation by Garnero, P, Ferreras, M, Karsdal, MA, Nicamhlaoibh, R, Risteli, J, Borel, O, Qvist, P, Delmas, PD, Foged, NT, Delaissé, JM

    Published in Journal of bone and mineral research (01-05-2003)
    “…Bone resorption may generate collagen fragments such as ICTP and CTX, which can be quantified in serum and/or urine by using specific immunoassays, and which…”
    Get full text
    Journal Article
  20. 20

    Quantification of immature and mature collagen crosslinks by liquid chromatography–electrospray ionization mass spectrometry in connective tissues by Gineyts, E., Borel, O., Chapurlat, R., Garnero, P.

    “…We describe a novel high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–ESI-MS) method for the simultaneous quantification…”
    Get full text
    Journal Article